Fabbco Bio Cycle And Bio Protein Technology Profile
Key Indicators
- Authorised Capital ₹ 1.90 Cr
as on 28-05-2024
- Paid Up Capital ₹ 1.07 Cr
as on 28-05-2024
- Company Age 1 Year 5 Months
About Fabbco Bio Cycle And Bio Protein Technology
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.90 Cr and a paid-up capital of Rs 1.07 Cr, as per Ministry of Corporate Affairs (MCA) records.
Latheef Moideenkutty, Niyas Valappil, Nishad Moidunni, and Three other members serve as directors at the Company.
- CIN/LLPIN
U10801KL2023PTC082141
- Company No.
082141
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jun 2023
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Company Details
- Location
Palakkad, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Fabbco Bio Cycle And Bio Protein Technology?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parambil Adathi  | Managing Director | 29-Jun-2023 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Niyas Valappil | Director | 29-Jun-2023 | Current |
| Latheef Moideenkutty | Director | Current | |
| Nishad Moidunni | Director | Current | |
| Melayil Razak | Director | 29-Jun-2023 | Current |
| Ambalathveettil Ramshad | Director | Current |
Financial Performance and Corporate Structure Insights of Fabbco Bio Cycle And Bio Protein Technology.
Enhance accessibility to Fabbco Bio Cycle And Bio Protein Technology's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Fabbco Bio Cycle And Bio Protein Technology?
Unlock access to Fabbco Bio Cycle And Bio Protein Technology's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Rajadhani Minerals Private LimitedActive 9 years 5 monthsLatheef Moideenkutty and Niyas Valappil are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Fabbco Bio Cycle And Bio Protein Technology?
Unlock and access historical data on people associated with Fabbco Bio Cycle And Bio Protein Technology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fabbco Bio Cycle And Bio Protein Technology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fabbco Bio Cycle And Bio Protein Technology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.